Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-25-002577
Filing Date
2025-01-07
Accepted
2025-01-07 08:01:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d875374dsctota.htm SC TO-T/A 32878
  Complete submission text file 0001193125-25-002577.txt   34635
Mailing Address 1 DNA WAY, MS #24, SOUTH SAN FRANCISCO CA 94080
Business Address C/O THE CORPORATION TRUST, 1209 ORANGE STREET, WILMINGTON, DE 19801 650 225-7893
ROCHE HOLDINGS INC (Filed by) CIK: 0000904566 (see all company filings)

IRS No.: 510304944 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 0000

Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Subject) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-91606 | Film No.: 25513494
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)